Both in Biotechnology
Senti Biosciences Holdings vs AIM ImmunoTech
Over the past year SNTI returned −90.2% and AIM returned −89.9%; their daily moves had a correlation of 0.01.
SNTI −90.2% AIM −89.9%Growth of $1, one year, split-adjusted
| Metric | SNTI | AIM |
|---|---|---|
| Price | $0.1766 | $0.1610 |
| Market cap | $6.8M | $6.4M |
| Today | −0.73% | +0.19% |
| 1 month | −45.3% | −11.8% |
| 6 months | −81.8% | −66.5% |
| Year to date | −83.0% | −85.7% |
| 1 year | −91.2% | −92.0% |
| Revenue growth (YoY) | — | +4.0% |
| Gross margin | 100.0% | 80.8% |
| Net margin | −75000.0% | −26876.9% |
| P/E (TTM) | — | — |
| Price / sales | 123.5× | 67.6× |
| Net cash | $2.5M | $6.3M |
| Dividend yield | — | — |
| Volatility (60d) | 115.4% | 67.9% |
| Short % of float | 4.1% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).